A groundbreaking shift in our drug policy has happened, as the regulators announce the use of psilocybin hallucinogens for therapeutic applications. Before this, these substances were heavily restricted, but a increasing body of research suggests they potentially offer aid for mental health conditions like anxiety. The new policy represents a major